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Various secondary plantmetabolites or phytochemicals, includingpolyphenols and carotenoids,
have been associated with a variety of health benefits, such as reduced incidence of type 2 dia-
betes, cardiovascular diseases, and several types of cancer, most likely due to their involvement
in ameliorating inflammation and oxidative stress. However, discrepancies exist between their
putative effects when comparing observational and intervention studies, especially when us-
ing pure compounds. These discrepancies may in part be explained by differences in intake
levels and their bioavailability. Prior to exerting their bioactivity, these compounds must be
made bioavailable, and considerable differences may arise due to their matrix release, changes
during digestion, uptake, metabolism, and biodistribution, even before considering dose- and
host-related factors. Though many insights have been gained on factors affecting secondary
plant metabolite bioavailability, many gaps still exist in our knowledge. In this position paper,
we highlight several major gaps in our understanding of phytochemical bioavailability, includ-
ing effects of food processing, changes during digestion, involvement of cellular transporters
in influx/efflux through the gastrointestinal epithelium, changes during colonic fermentation,
and their phase I and phase II metabolism following absorption.
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1 Introduction
Phytochemicals comprise a diverse group of secondary plant
compounds, including polyphenols, carotenoids, triterpenes,
phytosterols, glucosinolates, and many more. These com-
pounds have aroused increasing interest in the area of
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nutrition and food science, due to their potential health bene-
fits. Several epidemiological studies have suggested that their
consumption or tissue concentration is associated with re-
duced risk of developing certain chronic diseases, namely,
type 2 diabetes (T2D), cardiovascular diseases (CVD), and
some types of cancer. For example, meta-analyses have sug-
gested that the consumption of flavonoids from fruits and
vegetables improved flow-mediated dilation, a marker of
atherosclerosis [1], and suggested positive health effects of
consuming carotenoids with respect to type 2 diabetes [2].
However, though a few examples of intervention stud-
ies with isolated compounds, e.g. resveratrol, or curcumin
[3, 4], producing positive health effects exist, micronutri-
ents and phytochemicals may not act efficiently in isolation
but together with many other compounds in the food ma-
trix, leading to synergistic effects [5]. It is thus important
to determine efficacy, safety and underlying mechanisms of
these compounds, especially when taken in pharmaceutical
doses/in combination with other drugs. For example, Prasain
et al. [6] reviewed risks and benefits of dietary versus sup-
plemented/isolated flavonoids, stating that flavonoids can be
detrimental in some settings and therefore are not universally
safe. Adverse effects were also found following the ingestion
of beta-carotene supplements administrated to CVD patients
[7,8], and vitaminC andE aswell as beta-carotene supplemen-
tation failed to show health benefits with respect to CVD [9].
Supplementing individual flavonoids and isoflavonoids has
also beenmet with criticism, e.g. due to endocrine disrupting
properties for higher doses [10]. The reasons for this discrep-
ancy are not fully understood, but could involve “missing”
synergistic effects with the food matrix, altered digestion and
release of the compounds or changed degradation patterns,
i.e.modified bioavailability (the fraction of a compound that is
absorbed and can be used for physiological functions and/or
storage). Indeed, many reviews on bioavailability and bioac-
tivity of phytochemicals are available [11–13]. Phytochemicals
may havemultiple functions in the human body, and depend-
ing on their dose they can exert both beneficial anddeleterious
effects [14].
This position paper attempts to identify the aspects of
digestion, release, absorption and metabolism of food phy-
tochemicals which are only poorly understood (Table 1) [15].
Even prior to ingestion processing factors (food texture, e.g.
heat, temperature, or pressure application [16]) can impinge
on the bioaccessibility (fraction of a compound that is re-
leased from the matrix and potentially available for further
uptake and absorption) of bioactives [17]. Similarly, the influ-
ence of consuming a mixed diet, i.e. “real” complex meals,
on bioaccessibility and absorption is poorly comprehended,
and biochemical and physico-chemical aspects such as vis-
cosity and surface tension surely play a role [18]. Following
ingestion, enzyme concentrations, pH, and time of digestion
all play a role and influence release kinetics and degradation
patterns [19, 20]. A factor that is also poorly understood is
the nature and bioactivity of metabolites formed during di-
gestion, as following their fate is challenging. However, the
bioavailability of some compounds and theirmetabolitesmay
be higher than previously assumed, as shown, e.g. in isotope
studies with anthocyanins [21]. Some lipophilic compounds,
such as carotenoids or triterpenes, require micellarization,
as may certain polyphenol aglycones [22]. Following release,
pathways of absorption, i.e. active versus passive or paracel-
lular routes remain largely marginally understood. The same
is true for influx and efflux transporters in the epithelium.
For example, several polyphenols were shown to be consid-
erably better absorbed in the presence of additional polyphe-
nols, blocking efflux transporters (to the gut), which normally
reduce the intracellular concentration of such “xenobiotics”
[19]. On the other hand, transporters to the basolateral side
are hardly understood. Finally, many native phytochemicals
undergo considerable metabolism in the human body, e.g.
deglycosylation and glucuronidation/sulfation for polyphe-
nols in the gut, cleavage by beta-carotene oxygenase 1 and
beta-carotene dioxygenase 2 for carotenoids [23], and many
additional reactions may occur in other tissues such as in
the liver or in the colon, where bacterial fermentation signif-
icantly alters the structure and profile and thus the potential
bioactivity of many plant compounds that are not absorbed
in the small intestine [24–26].
In this paper, we aim to highlight gaps that have received
either limited attention or which are far from being under-
stood, but whichmay play pivotal roles in the bioavailability of
phytochemicals (Fig. 1). To allow for better focus, this review
will concentrate on polyphenols and their metabolites as the
most abundant water-soluble compounds, and carotenoids
as the most abundant lipophilic secondary plant compounds.
For amore comprehensive overview on bioavailability aspects
of specific compound classes, the reader is referred to other
articles [22, 27, 28].
2 Food processing and matrix effects
Bioaccessibility, and further bioavailability, of phytochemi-
cals starts with their content and composition of the raw
plant material and how it is processed. The food matrix and
structure and type of processing can have both positive and
negative effects [29]. Plant matrix disruption and cell cluster
disintegration due to applied processing steps are the main
prerequisites for phytochemical liberation and bioaccessibil-
ity, but they may also lead to oxidation and/or degradation,
thus potentially counterbalancing each other.
To understand the release of bioactive compounds dur-
ing digestion, it is also important to know where they are
located in the tissue. Carotenoids are found either in the
chloroplast membrane or in chromoplasts [30]. The differ-
ent physical forms of carotenoids in plant chromoplasts
(crystals in tomato, lipid-dissolved in papaya and liquid-
crystalline in mango) have major impacts on their liberation
efficiency from the foodmatrix [31]. Polyphenols are generally
present in vacuoles and the apoplast of plant cells, in conju-
gated form with mono- and polysaccharides, and proteins.
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Table 1. Summary of major gaps of knowledge around phytochemical bioavailability
Stage Knowledge gap Examples Reference
examples
Food matrix Physical state/compartmentalization of
phytochemicals
Crystallinity of carotenoids in
chromoplasts versus chloroplasts,
polyphenols bound to cell wall (NEPP)
[31,107]
Food preparation Effect of cutting, mashing, grinding,
peeling, trimming





Food processing Effect of cooking (heat, temperature,
time, blanching)
Enhanced carotenoid content with mild
conditions but decreased with severe
treatments
[16,52,53]
Refining processes Bleaching, deodorization: decreasing
carotenoid content
Milling enhancing polyphenol
extractability through surface area
[40–42]
Nonthermal processing (HPP and PEF) Both positive (polyphenols) and
contradictory effects (carotenoids)
[67,69]
Food mixtures Effect of mixed or real meals Enhanced availability of polyphenols
with presence of sugars, ascorbic acid,
fat. Stabilizing effects of polyphenols
on other phytochemicals?
[77,81,193]
Gastric digestion Effect of pH, depolymerization of large
polyphenols, binding effects
Hydrophobic interactions, hydrogen
bonding of polyphenols to proteins
[19]
Small intestine Micelle formation
Role of uptake transporters
Transition from matrix to oil phase,
micelle size, number, and stability





Efflux transporters such as P-gp, BCRP





Effect of polyphenols on efflux




SRB-1, CD36, NPC1L1, ABCG5/G8:
affecting carotenoid uptake – influence
of polyphenols
[19,197,198]
Colon Phase I/II interactions Piperine increased curcumin absorption [146]
Influence of microflora
Colonic absorption
Metabolite formation, absorption of
cleavage products?
[102,172,190]
Metabolites and phase I/II products Metabolite information limited by lack of
standards
[160,161]
Tissues Biotransformation, phase I and phase II
metabolism
Need to develop/increased availability of
more physiological cell models (liver
stem cells, co-culture cell models) to
study metabolites
[125,152–155]
Interaction with transporters in certain
tissues (blood–brain barrier, placenta,
testis), or excretory organs (liver,
kidney)
Role of MRPs, MCTs, CD36 [140,184,185]
ABCG5/G8 = ATP-binding cassette sub-family G, member 5/8; BCRP = Breast cancer resistance protein; CD36 = cluster of differentiation;
HPP = high pressure processing; MCTs = monocarboxylic acid transporters; MRP = multidrug resistance protein; NEPP = non-extractable
polyphenols; NPC1L1 = Niemann-Pick C1-Like 1; PEF = pulsed electric fields; P-gp = P-glycoprotein; SRB-1 = scavenger receptor class B
member 1.
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Figure 1. Overview of important stages during the digestion of food items and open questions related to phytochemical bioavailability.
Although studies have focused mainly on the cellular local-
ization of carotenoids, polyphenols, and more rarely on glu-
cosinolates, more research on their localization in different
foods is needed. Little is known about other phytochemicals.
2.1 Effects of physical and mechanical treatments
Food preparation (such as grating, chopping, cutting, slicing,
trimming, mashing, and juicing) may have great influence
on the bioaccessibility of nutrients and bioactive compounds
[30, 32]. The recovery of phytochemicals from intact, mini-
mally processed fruits and vegetables can be different from
juices as components must be released from the tissue ma-
trix before being subject to degradation reactions, whereas
those in the juices are subject to degradation from the offset.
However, carotenoid bioacessibility was greater from juiced
than from raw or cooked pure´ed tissue, as chopping and ho-
mogenization disrupted the plant matrix [32]. The levels of
carotenoids in sea buckthorn berries were lower if the berries
were extracted in water or juiced than after direct acetone
extraction. This appears to be due to the complexation of
carotenoids with pectins [33], and similar interactions may
also occur between pectins and polyphenols, such as antho-
cyanins, during digestion [34].
Other phytochemicals are subject to endogenous enzy-
matic digestion. Chopping or crushing raw garlic releases
alliinase which produces allicin, which breaks down to di-
allyl sulfides and then other metabolites, which may influ-
ence chronic diseases and certain cancers [35, 36]. Similarly,
the glucosinolate glucobrassicin, which is found in crucifer-
ous vegetables, is hydrolyzed when plant cells are damaged
[37]. On the other hand, flavonoids seem relatively stable
to mechanical processing [38]. Peeling and trimming steps
may also influence phytochemical content. Trimming green
leafy vegetables is known to be a main factor influencing
carotenoid concentrations, since they are nearly exclusively
present in leaves [39]. Also industrial refining processes, e.g.
as applied to vegetable oils and cereals, may lead to high
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losses in phytochemicals. Refining of palm oil decreased
carotenoids by 99%, and polyphenols by 23% [40,41].
Milling of cereals and grains has a great influence on phe-
nolic acids [42]. It is well known that milling of the whole
grain results in higher amounts of phenolics than conven-
tional milling resulting in white flour [43]. Many studies have
investigated the effects of refining on phytochemicals in ed-
ible oils and cereals but similar studies on vegetables and
fruits (except juices) are largely absent.
In conclusion, although there are many studies reporting
effects of food preparation on the bioaccessibility of polyphe-
nols and carotenoids, understanding the mechanisms of
chemical or enzymatic actions still requires extensive work.
In addition, as novel methods are developed, further studies
on how these processes impact bioaccessibility and bioavail-
ability are warranted.
2.2 Effects of thermal and nonthermal treatments
Studies of thermal treatment onphytochemicals in foodshave
mainly focused on polyphenols, carotenoids and glucosino-
lates.Many reports indicate that thermal processing increases
levels of free polyphenols [44–47], possibly due to the re-
lease of bound phenolics due to the breakdown of cell con-
stituents, perhaps through releasing nonextractable polyphe-
nols (NEPP). However, also polymerization/oxidation reac-
tions may be responsible for apparent increases [44, 45], and
the nature of these released polyphenols requires investiga-
tion. Similarly, carotenoid availability often increases after
heat treatment [48–51], probably due to enhanced extractabil-
ity following maceration of cells. However, severe heat treat-
ment such as baking/sterilization of tomatoes [52,53] or boil-
ing of chili peppers [54] caused significant losses. Losses of
glucosinolates in Brassica vegetables depended on process-
ing time, type of vegetable, degree of cellular damage, and
inactivation of myrosinase [55–60]. Overall, further research
is required to better explain how thermal treatments impact
bioaccessibility and bioavailability.
Nonthermal processing technologies have been revealed
as useful tools to extend shelf-life and to preserve nutritional
and functional characteristics of fruit and vegetable products
[61]. However, there are scarce data on the effect of these
emerging technologies on bioaccessibility and bioavailability
of bioactive compounds. Considering bioaccessibility, studies
havemainly focused on the effect of high pressure processing
on carotenoids, with contradictory results. Some show im-
provements [16,62–66], possibly related to the disintegration
of cell clusters and disruption of cells containing carotenoids.
Beneficial effects of a subsequent thermal treatment may
weaken the physical barriers that enclose carotenoids and
accelerate pectin degradation by -elimination, resulting in
cell wall softening. Decreased carotenoid bioaccessibility has
been noted in some vegetables and fruits and may be due to
firmer texture and/or trapping of carotenoids within fiber
networks [62, 63]. Thus, processing variables (e.g. particle
size, temperature, pressure applied) need to be carefully con-
trolled, and there is a need for harmonization and validation
(by comparison with in vivo assays) of the in vitro digestion
models used.
Regarding human bioavailability, high pressure process-
ing increased absorption of orange juice flavanones over con-
ventionally pasteurized orange juice [67]. No data are available
for carotenoids. To our knowledge, the effect of pulsed electric
fields has been investigated only on vitamin C bioavailability
in humans from orange juice [68] and Mediterranean veg-
etable soup [69]. No studies addressing the effect of pulsed
electric field on carotenoid and polyphenol bioaccessibility
and bioavailability are available. Other nonthermal process-
ing technologies such as ultrasound [70], food irradiation,
light pulses or oscillating magnetic fields, have received little
or no attention in terms of their effect on bioaccessibility and
bioavailability of phytochemicals. Thus, more studies in this
field may be required especially as more novel processing
techniques are being developed.
3 Mixtures of authentic food matrices
There has been comparatively little effort into assessing the
effects of characteristic combinations of foodstuffs or realistic
meals on the bioaccessability of phytochemicals. However,
studies have shown that polyphenols from foods in com-
binations can have very different bioaccessibilities. Studies
with raspberry juice showed that the addition of ice-cream
markedly reduced the recovery of total anthocyanins [71],
whereas a wheat-based breakfast cereal did not influence re-
covery. Co-digestion with blueberries± oat meal and/or milk
revealed that milk reduced the recovery of total anthocyanins
and total phenols [72] and co-digestion of nuts and dried fruits
yielded lower levels of total available phenols after simulated
digestion than nuts or fruits alone.
The addition of bovine, soy and rice milks, ascorbic acid
or citrus juices increased the bioaccessibility of galloylated
green tea catechins (EGC, EGCG, EC, and ECG), by stabi-
lization and protection from degradation at alkaline pH [73].
The simultaneous presence of sucrose and ascorbic acid in
green tea increased EGC and EGCG bioaccessibility, uptake
in Caco-2 cells and bioavailability in rats [74]. Although the
addition of skimmed milk reduced recovery of green tea cat-
echins after in vitro digestion, the uptake of catechins by
Caco-2 cells was increased [75]. This suggests that catechins
bound to the milk proteins after in vitro digestion were avail-
able for uptake by the Caco-2 cells. This may explain the lack
of difference in serum/plasma bioavailability of tea catechins
in studies where subjects were given tea with or without milk
[76]. Similarly, chocolate containing higher sucrose levels in-
creased plasma concentrations of metabolites derived from
catechins compared to dark andmilk chocolate in rats [77]. In
humans, sucrose but also solid/beverage format influenced
various aspects of the bioavailability of flavan-3-ols from
commercial cocoa based products [78]. Dietary fats can
C© 2015 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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increase polyphenol bioavailability in humans by increas-
ing absorption, possibly by enhancing micellarization in the
small intestine [79, 80], as noted for carotenoids. For ex-
ample, higher fat content increased the stability of cocoa
procyanidins during in vitro digestion [81]. This is partic-
ularly relevant as screening of different formulations (or
different plant varieties) for the bioaccessibility of specific
phytochemical components has become more common and
it is possible that variations in other macronutrients influ-
ence the outcome. Using experience gained in pharmaceuti-
cal applications, strategies may also be designed to improve
polyphenol bioavailability by co-administering phenolics with
compounds which modulate gut and/or liver metabolizing
enzymes [80, 82, 83].
There is definitely more scope for the study of food mix-
tures that are more realistic of real meal choices. Complex
models developed by the pharmaceutical industry to assess
the digestion behavior of different drug formulations [84,85]
could be applied to estimate digestion of foods. Despite the
increasing complexity achieved by in vitro models, they re-
main simple compared to in vivo models. Typical limitations
of in vitro models include: absence of host response factors,
poor stimulation of complex mechanical forces and gastric
emptying, absence of microbial flora, low level of integra-
tion into an overall digestive process, general adherence to
healthy/average conditions, and limited correlation to in vivo
situations [86]. Nevertheless, some examples have indicated
a reasonable correlation between bioaccessibility studies and
the situation in vivo. For lipophilic compounds such as- and
-tocopherol, -carotene and lycopene [87], -cryptoxanthin
[88] or phytosterols [89], high correlations have been found,
indicating that estimating in vitro bioaccessibility (solubil-
ity/micellarization) can be indicative of the amount avail-
able for uptake in the GI tract in vivo. For polyphenols,
comparisons to in vitro data have been allowed by studying
ileostomists [15]. In addition, combining in vitro digestion
models and human intestinal cells (e.g. Caco-2 cells with
or without a layer of mucus-producing cells such as HT-29
MTX), carotenoid uptake [90–92] qualitatively and quantita-
tively correlated well with human data. Investigators using in
vitro methods must consider how to adapt the digestion con-
ditions according to the composition of the sample and/or to
food components, seeking a balance between technical sim-
plification and accuracy, considering the in vivo situation as
reference.
However, the release of phytochemicals from different
foods is complex and involves large numbers of variables
[93–95]. Furthermore, the transfer of phytochemicals from
authentic food matrices will be even more complex due to
a greater number of potentially rate-determining processes.
Digestion and absorption rates are limited by physical pro-
cesses, operating within and between the different phases of
the liquid and solid phases of the digesta [96].Usingmodels of
the human stomach [95, 97], distinct disintegration profiles
and kinetics have been found for different food categories
(e.g. meat products, nuts, fruits, baked and fried products,
etc.). The digestion process in terms of secretion of gastric
fluids and enzymatic degradation of macronutrients is well
understood, but further detailed investigations are needed to
understand lipid absorption and to predict responses in re-
alistic meals. Further information on the release of bioactive
compounds should provide a better understanding of how to
combine foods and design meals to improve bioavailability
and enhance potential bioactive effects.
Encapsulation may enhance the bio-effectiveness of phy-
tochemicals, and the choice of encapsulation agent can in-
fluence stability/recovery after digestion [98]. For example,
Haratifar et al. [99] found that casein micelles were effec-
tive encapsulation agents for EGCG. A novel approach in-
volving biosorption of phenolics to Saccharomyces cerevisiae
significantly improved bioaccessibility of total phenolics, pre-
sumably as the yeast provided a protective carrier against
degradation at neutral pH [100].
The possibility that certain phytochemical classes could
protect other phytochemicals is an interesting, but largely
under-researched area. The fact that the stability of individ-
ual phytochemical classes may be dependent on the over-
all phenolic composition of the sample has been raised in
studies of berry polyphenol bioaccessibility [101, 102]. This
interdependence could be examined in studies where blends
of juices are tested for bioaccessibility of a range of phyto-
chemical components such as vitamin C, carotenoids, and
polyphenols [103]. The possibility that polyphenols may sac-
rificially protect carotenoids or vitamin C (or vice versa) could
also be examined. For example, the effect of anthocyanins on
carotenoid stability could be examined in comparative studies
of purple tomatoes and related red tomatoes [104] or indeed in
the recently genetically modified anthocyanin-accumulating
tomatoes over their non-genetically modified counterparts
[105]. Combining foodstuffs, therefore, may provide another
route to enhance the bioaccessibility of specific health benefi-
cial components. Vice versa, it has been claimed that polyphe-
nols may modulate the digestion of macronutrients (such as
starches or fats) through inhibition of their digestive enzymes
[106], which could possiblymodulate their own stability in the
gut. The possibility that the underestimated NEPP content of
fruits/vegetables [107] could influence the activity of diges-
tive enzymes or limit the access of certain phytonutrients to
digestive processes could be examined in carefully designed
studies where the effect of in vitro digestion on the phy-
tochemical profile of whole fruit/vegetable purees was com-
pared to extracts and cross-compared to re-combined samples
containing NEPP plus extracts.
There has been a general shift away from measuring the
levels of total phytochemical classes (e.g. total carotenoids
and phenolics) to targeted analysis of compositional changes
in specific components during digestion, as this is more rel-
evant to the potential health benefits attributable to specific
phytochemicals. However, greater value could be obtained
by using an untargeted, metabolic profiling approach which
could also identify potential breakdown products and other
novel components.
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4 Gastric phase and small intestine
The absorption of secondary plant components includes sev-
eral phases (outlined below), and prominent gaps in our
knowledge include factors influencing solubilization, micelle
formation (of apolar compounds), diffusion to the unstirred
water layer (including the influence of mucus), transporters
involved in the uptake of phytochemicals, and factors affect-
ing phase I/II metabolism and efflux pumps.
4.1 Release from the food matrix
Aspects impeding the release of phytochemicals include large
particle size [108], highmeal viscosity [18] reducing the trans-
fer of lipophilic compounds to micelles and hindering inter-
actions between lipase and oil droplets [109]; or the presence
of physically inaccessible forms such asNEPP [19,110]. As the
majority of micronutrients and phytochemicals are presum-
ably taken up in the small intestine (in their native form), and
the epithelial “leakiness” decreases toward the colon [111], it
is important that compounds are bioaccessible at this stage.
Many polyphenols may not be detectable in the native matrix
following chemical extraction, but may be released during di-
gestion in the small intestine, such as those bound covalently
or occluded by e.g. in accessible starch [112], though colonic
fermentation may further result in the breakdown of NEPPs
[113]. Standardized methodologies which recognize and ex-
amine the potential contribution of NEPPs are required. It
also has to be noted that polyphenols have the ability to re-
duce the activity of digestion enzymes (e.g. pepsin, lipase),
thus high concentrations of polyphenols may reduce libera-
tion of lipids and proteins, increasing the nondigestible bulk
and in turn may result in increased amounts of polyphenols
passed onto the colon [19].
4.2 Solubilization and micellarization
Solubility is not an issue for most polyphenols, but more
lipophilic compounds such as carotenoids [114], triter-
penes [115], and phytosterols [116] require emulsifica-
tion/micellarization before uptake. It remains largely un-
known to what extent digestion and food matrix influence
micelle formation or size. Large micelles would compromise
diffusion and subsequent release of apolar compounds. Mi-
celle diameters of approximately 6–8 nm [117,118] have been
measured, but the relation of micelle size, shape, or con-
stituents, and cellular uptake has never been studied in de-
tail. Also, surprisingly little is known about the influence of
dietary lipids and their digestion on polyphenol uptake [19],
though there are indications that certain apolar polyphenols
(e.g. curcumin, resveratrol, quercetin aglycones) are incor-
porated into micelles, and that lipid-rich foods may enhance
their bioavailability [79, 119–121].
A poorly understood factor in bioavailability is the
role of brush border membrane enzymes, i.e. maltase,
lactase-phlorizin-hydrolase, sucrase-isomaltase, and pepti-
dases [122]. Lactase-phlorizin-hydrolase may play a crucial
role in cleaving polyphenol glycosides, resulting in the uptake
of free aglyones [123,124]. However, it is not certain whether
cleavage occurs at this stage, by cytosolic-beta-glucosidase
[19], or by colonic microbial action. The presence of esterases
in the brush-border, surely present in the enterocyte [125],
has been speculated on, which would influence polyphenol
esters such as chlorogenic acid, or xanthophyll esters, though
cholesterol esterase may also act on the latter [126].
While proteins can exert negative effects on polyphenol
bioavailability [127], the interaction of apolar phytochemcials
and proteins during digestion has never been studied system-
atically, though certain proteinsmay aid in the emulsification
of lipid soluble phytochemicals [128]. Contrarily, a positive
effect of sugars on polyphenol glucoside uptake [via stimu-
lation of sodium-glucose linked transporter 1 (SGLT-1)] has
been suggested [129]. The effect of dietary fibers is assumed
to be negative, due to gel formation, enhanced viscosity, or
binding and entrapping of phytochemicals, but the effects
of soluble versus insoluble, or prebiotic fiber are largely un-
known. Other interactions with the food matrix exist during
digestion, such as high concentrations of minerals impeding
micelle formation [130], but their relevance in bioavailability
remains unclear.
4.3 Cellular uptake
Prior to reaching the cellular surface, diffusion through the
mucus [122] is required, though properties influencing dif-
fusion are poorly understood. Viscosity and particle/micelle
size of the digesta are expected to play a role. Porcine tri-
als have shown that smaller particles diffuse more readily
through the mucus layer [131]; and it may be assumed that
apolar compounds are likewise hindered [132]. More sophis-
ticated model studies including mucus-producing cells, such
as HT-29-MTX, are still rare but warranted.
Cellular uptake can occur by transcellular or paracellu-
lar routes. The latter is reserved for rather polar and small
molecules<600Da [133], i.e. ions, water, sugars, etc., as these
pass through the tight junctions of the epithelium. Most phy-
tochemicals are taken up via transcellular transport. Certain
compounds (such as apple polyphenols) increase tight junc-
tion functionality [134], possibly via altered cellular signal-
ing transduction pathways [135]. On the other hand, certain
fatty acids (such as caprylic acid) and high molecular weight
polyphenols reduced tight junction barrier function, andmay
enhance uptake of other small compounds [134, 136, 137].
Transcellular uptake can occur by facilitated, active means
or via passive diffusion. The latter is reserved for small
and apolar molecules, as these readily pass through the cell
membrane [138]. Passive diffusion has been suggested for
carotenoids [22, 23] and some apolar polyphenol aglycones
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[19]. At low concentrations, presumably similar to levels of an
average mixed diet, these compounds may also be taken up
by carriers, actively or by facilitated diffusion. Over 400 trans-
membrane carrier proteins are known [139]. Many polyphe-
nols can inhibit these transporters, but stimulation was also
described [140] and effects may depend on the polyphenol
type, its concentration, exposure time, cell type, and sub-
strate. For carotenoids, high concentrations of beta-carotene
reduced lutein uptake [141], which may be explained by
higher affinity to transporters such as cluster of differenti-
ation 36 (CD36) or unknown types [142]. Enhanced uptake
of polyphenol glucosides by sugars via SGLT-1 activation
[19, 143] is known, but the involvement of gut transporters
other than SGLT-1 and mono-carboxyl-transporter 1 (MCT1)
for polyphenols is not certain, andmost polyphenol aglycones
are assumed to be taken up by passive diffusion [124].
4.4 First pass metabolism
A large number of metabolites can be formed following
phase I (e.g. reduction/oxidation, methylation, hydrox-
ylation, hydrolysis, e.g. via cytochrome P450-dependent
mixed-function oxidases (CYPs) and catechol-O-methyl-
transferase) and phase II metabolism (e.g. glucuronidation
by uridine-5’-diphosphate glucuronosyltransferase, and
sulfation via sulfotransferases), in human enterocytes
[144, 145]. Certain phytochemicals can up- or downregulate
these enzymes, influencing the availability of the native com-
pounds. For example, uptake of curcumin was approximately
20-fold enhanced when co-administered with piperine in
humans [146]. High doses of certain polyphenols may
override phase I/II metabolism, though not much is known
on thresholds in this respect [19]. Such interactions are
certainly a gap in our knowledge. For carotenoids, cleavage
by beta-cartotene oxygenase 1/beta-carotene dioxygenase
2 results in symmetric/asymmetric cleavage, producing
apo-carotenals. However, these reactions are far from
quantitative, and appear to depend on genetic factors and
the type of carotenoid [23]. The bioactivities of apo-carotenals
(except retinols) are poorly comprehended, though they may
be highly effective, e.g. in activating nuclear receptors [147].
Detecting small amounts of these compounds is difficult,
and suitable standards are often not commercially available.
4.5 Transport through the epithelium
Many phytochemicals are treated as xenobiotics, expelled
from the cell, typically by increasing their polarity and via
efflux transporters. These transmembrane proteins are typ-
ically ATP-dependent efflux pumps. Little is known on the
specificity of these transporters, and less on the potential of
phytochemicals or nutrients to block them,which could result
in enhanced bioavailability. It is assumed that P-glycoprotein,
MRP2 (multidrug resistance protein 2), and breast cancer re-
sistance protein (BCRP) are the most important transporters,
and that thesemay be competitively inhibited by polyphenols,
perhaps by blocking ATPase [19]. The transport from the cell
to the basolateral side (i.e. bloodstream or lymph) is even
more poorly understood. Compounds that could increase
or decrease MRP3 (or MRP1, MRP4, and possibly several
MCTs), could affect polyphenol uptake, as e.g. demonstrated
by mice overexpressing MRP3 and showing high resveratrol
bioavailability [148]. It is assumed that carotenoids can be
transported back into the lumen by scavenger receptor class
B member 1 and possibly ATP-binding cassette subfamily G,
member 5/8, butmore research is needed. Transport through
the cells, e.g. by transporters such as fatty acid binding pro-
teins is assumed, but not confirmed [23]. It can be further as-
sumed that proteins involved in chylomicron generation [i.e.
microsomal triglyceride transfer protein, apoB48, apoAIV,
and Sar1b [23, 149], also influence carotenoid transport. For
polyphenols, transport through the cells is not understood,
and may occur primarily by diffusion.
5 Metabolism in the colon and other
organs
5.1 Metabolism of polyphenols
In general, polyphenol metabolism is fairly well known due
to their xenobiotic nature. Polyphenols undergo metabolism
in intestinal and liver tissues and by colon microbiota [15]. In
fact, it seems that the colon may be the major important site
for polyphenol uptake, at least for orange juice rich in hes-
peritin and naringin [150], and studies with ileostomists sug-
gested significant absorption from the colon [151]. Phenolic
compounds are glucuronidated and sulfated in the liver and
intestinal tissues, and thesemetabolites are found in body flu-
ids [125, 152–155]. Hepatic metabolites can be recycled back
to the small intestine through biliary excretion [27, 156–159]
and end up in the colon, where they are deglucuronidated by
microbial , D-glucuronidases before ring fission [160, 161].
Sophisticated methods for studying enterohepatic circu-
lation, including humans, using a perfusion technique, have
been published [162, 163], in addition to various articles on
tissue metabolites of phenolic compounds [164], e.g. flavanol
monomers and tea polyphenols. However, the enterohepatic
circulation of colonic metabolites requires further investiga-
tion and hepatic metabolism of colonic metabolites of plant
phenolic compounds should be addressed in the future [162].
Furthermore, Monagas et al. [165] suggested that microbial
metabolites may act as signal molecules, and their action
should be taken into account in more detail in future investi-
gations.
Absorbed microbial-derived metabolites (such as en-
terolignans and dihydroxylated compounds such as methyl
catechol) can be subjected to further glucuronidation, methy-
lation, sulfation, or glycination in the liver, while phase I
metabolism (oxidation/reduction reactions) seems to occur
C© 2015 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
Mol. Nutr. Food Res. 2015, 00, 1–17 9
to a lesser extent [27]. The interplay between the liver and the
colon, the enterohepatic circulation, leads to a long residence
time (up to 24–48 h) in the blood [157, 162, 166–168], which
can gounobserved unless longer sampling of blood or urine is
carried out [164,169]. Finally, the phenolic microbial metabo-
lites are distributed to tissues and are excreted via urine, partly
as free but mainly as hepatic conjugates, depending on the
structure of the parent backbone [125, 157, 158].
One of the major gaps is the lack of knowledge concern-
ing hepatic conversion of small colon-derived phenolic acids,
which may be missed in analyses of human body fluids or
cell lines due to their hydrophilic nature. Extraction of sam-
ples may also cause bias, as Sawai et al. [157] elucidated the
ratio of excreted conjugated and free phenolic acid colon-
derived metabolites from quercetin derivatives in urine, by
using water saturated ethyl acetate to enhance the yield of
polar conjugates.
Although human studies are more relevant, mechanisms
of action can be studied using in vitro human-based cell
model systems designed to study properties of drugs [27].
In recent years, novel cell lines and culture strategies have
helped in overcoming the scarcity of human liver material
and problems in maintaining the expression and function
of metabolizing enzymes [170]. The advent of human stem
cell derived hepatocytes will potentially provide an unlim-
ited source of human hepatocytes [171]. Human hepatocyte
three-dimensional models, with complete hepatic metaboliz-
ing enzymes, transporters, and cofactors, may be applicable
to metabolite profiling, pathway identification, CYP450 inhi-
bition, CYP450 induction, and uptake and efflux transporter
inhibition by polyphenols and their metabolites.
The lack of standards for metabolites causes limitations to
study both polyphenol and phytosterol metabolism. Chem-
ical procedures and biochemical labeling tools are available
for the synthesis of many conjugated metabolites [172]. How-
ever, the absence of standards limits the use of some an-
alytical methodologies, and frequently enzyme treatment
is used to overcome the problem of hepatic conjugative
metabolism. For example, conjugated flavan-3-ol metabolites
are rarely available commercially, and most studies have an-
alyzed plasma and urine samples after treatment with glu-
curonidase/sulfatase, providing data only for the aglycones
[164]. However, some sulfate conjugates are resistant to en-
zyme hydrolysis, thus, this methodology may underestimate
bioavailability [173, 174]. This is the situation for estimat-
ing epicatechin bioavailability from cocoa products. Direct
analysis of the individual epicatechin metabolites by LC–
MS/MS may overcome this problem, however, the chiral-
ity of the aglycone will still be unknown, and it is plau-
sible that the enantiomers could differ in their biological
activity. Each flavan-3-ol and each associated phase II con-
jugate can, in theory, occur as four enantiomers, with the
(+) and (–) forms resolvable only by chiral chromatogra-
phy, and so far as we are aware there are no reports of chi-
ral analysis of conjugated metabolites in urine or plasma
[164].
However, targeted LC-MS analytical approaches can be
used for identifying many metabolites by exact mass, if a
theoretical prediction of possible metabolites and conjugates
based on expected metabolism is available [154]. Nontargeted
metabolomic profiling can find metabolites based on struc-
tural similarity to the parent compound, if the mass spectra
can be coupledwith a compound library. Profiling of phenolic
metabolomes has been assessed by NMR, GC, LC and 2D-GC
with TOF mass detection coupled with a compound library
[25, 175–178].
5.2 Metabolism of lipophilic compounds
Regarding lipophilic bioactive compounds, serum phytos-
terol bioavailability is reported to be below 10%, suggesting
that they may reach the colon and subjected to microbial
metabolism [179]. The pathway of microbial transformation
from sterol to stanol form in humans was reported in the
1970’s, but the kinetics of the reaction steps and metabo-
lites in the large intestine have not been studied systemat-
ically [180]. For carotenoids, the liver stores and distributes
carotenoids to other tissues, but the mechanisms are not
known accurately [181]. However, intervention studies have
shown that increased dietary intake of carotenoids influences
serum concentrations more than colon concentrations [182],
suggesting that absorption occurs mostly in the small intes-
tine. In addition, metabolites of lycopene produced in vivo
also occur naturally at low concentrations in tomato, which
causes difficulties in the differentiation of the origin of the
metabolites [183].
5.3 Transport, tissue distribution, and mechanism
of action
Transport of metabolites and their parent compounds to tis-
sues has not been studied adequately. This is important,
since it is the key action to ensure the desired biological
activity. There is a lack of information whether conjugated
polyphenols can prolong their residence time in the body
by modulating the activity of the transporters in the excre-
tory organs. A recent study of transmembrane transport of
flavonoids and some of their methylated and glucuronidated
metabolites using human cerebral microvessel endothelial
cells as a blood–brain barrier cell model [184] showed that
the metabolites were transported in a time-dependent man-
ner and showed higher transport efficiency than the native
flavonoids and were not further transformed by the cells.
Polyphenols affect their own metabolism and tissue distribu-
tion, due to their capacity tomodulate the activity of xenobiotic
metabolizing enzymes and transporters, modulating their
own concentration-time profiles in the body and also promot-
ing alterations in drug or toxin pharmacokinetics, the mech-
anisms of which are not known [140, 185]. Therefore, addi-
tive, synergistic, or antagonistic effects of xenobiotics (dietary
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phytochemicals, drugs, and toxins) need to be addressed. For
example, the downregulation of cytochrome P450 3A4 by
grapefruit juice and its polyphenols, enhancing the concen-
tration of several pharmaceuticals and increasing their effects
is well known [186]. Furthermore, the knowledge of pharma-
codynamics and tissue distribution for most polyphenols and
their metabolites is still lacking. It would also be relevant to
study individual variation in the tissue distribution and the
potential bioactivity caused by genetic variation in pathways
related to bioavailability and transport [187].
In vitro models for preclinical research using stem cells,
and patient-specific induced pluripotent stem cells and re-
programmed somatic cells from patients are already applied
in disease modeling and drug discovery, and may be appli-
cable to test polyphenol metabolite health benefits. Micro-
engineered physiological systems, also known as “organs-
on-chips”, can reconstitute physiologically critical features of
human tissues and their interactions [188]. The nematode
Caernohabditis elegans, with the presence of tissue and organ
systems, is increasingly used as an in vivo model and has
been employed to study the metabolism of methylated cate-
chin derivatives and their biological effects on oxidative and
thermal stress resistance [189]. Thus, novel cell assays and ne-
matode in vivo assays may be applied to study mechanisms
of action of the parent compounds versus their liver/colon
metabolites, although it should be noted that in vivo models
such as C. elegans orDrosophila (like mice) may produce quite
different metabolites from ingested phytochemicals than
humans.
Only a few studies have combined the assay of biological
effects of bioactive compounds or their colonic metabolites
fromwhole foods or their extractswith an in vitroGI digestion
process with/without colonic fermentation [102, 172, 190], or
compared the biological activity of metabolites to their parent
compound [178]. Furthermore, the synergistic effects of the
phytochemical metabolite pool, including the interplay be-
tween liver and colon microbiota should be studied. Finally,
cell-based assays measuring the bioactivity of the metabolites
at relevant concentration are scarce [102, 191, 192]. In the fu-
ture, bioactivity assays to mimic the actual in vivo situation in
the corresponding tissue, should use metabolite pools from
whole foods, at tissue-tolerant concentrations.
6 Conclusion
In this position paper, we have tried to highlight gaps of
knowledge with respect to selected phytochemicals. It has
to be noted that the data presented represent a somewhat
simple and general paradigm for phytochemicals, and that,
due to the very large variety and properties of secondary plant
compounds, the statements cannot be generalized toward all
groups of phytochemicals. In addition, some of the missing
aspects discussed in this paper may currently be tackled, but
have not been published.
However, while recent work has greatly enhanced our in-
sight into the metabolism and bioavailability of a range of
phytochemicals, many factors governing matrix release, sol-
ubilization, cellular uptake, and biotransformation remain
poorly understood. Major aspects which deserve more atten-
tion when estimating bioavailability aspects include effects
of innovative processing techniques, synergistic effects of
mixed/whole diets, factors effecting micelle formation, co-
constituents influencing influx and efflux via transporter sys-
tems or altering phase I/II metabolism, as these have often
been overlooked or excluded from consideration, in part due
to difficulties to include their study in vivo or in vitro. In the
future, enhanced availability of analytical possibilities to in-
vestigate these aspects such as through broader availability of
instruments tomeasure food texture, visualization ofmicelles
(TEM, Mastersizer), improved cell models of absorption and
metabolism (mucus producing, liver cells, 3D models), ways
to produce knock-out variants (e.g. of certain transporters)
in animal models (nematodes, mice, etc.) to study pathways
of absorption and bioactivity of metabolites, and improved
chromatographic techniques and commercial availability of
metabolites (e.g. sulfates and glucuronides) will aid toward
an improved understanding of these important aspects of
bioavailability.
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